Steris Plc Revenue Growth Rates (STE31), Current and Historic Growth - CSIMarket
CSIMarket
 


Steris Plc  (NYSE: STE31)
 

STE31's Revenue Growth by Quarter and Year

Steris Plc's Revenue results by quarter and year




STE31 Revenue (in millions $) FY 2023 FY 2022 FY 2021 FY 2020
4th Quarter March -
3rd Quarter December -
2nd Quarter September -
1st Quarter June 1,492.70
FY 1,492.70





STE31 Revenue first quarter 2023 Y/Y Growth Comment
Steris Plc achieved in the first quarter 2023, above Company average Revenue growth of 23.29% year on year, to $ 1,492.70 millions.

Looking into first quarter 2023 results within Medical Equipment & Supplies industry 68 other companies have achieved higher Revenue growth. While Steris Plc' s Revenue rise of 23.29% ranks overall at the positon no. 2141 in the first quarter 2023.




STE31 Revenue ( Y/Y Growth %) 2023
2022 2021 2020
4th Quarter March - -7.99 % 49.45 % 4.48 %
3rd Quarter December - -8.86 % 58.3 % 2.62 %
2nd Quarter September - 8.59 % 44.77 % -4 %
1st Quarter June 23.29 % 38.6 % 6.14 % 7.13 %
FY   - 5.13 % 38.96 % -

Financial Statements
Steris Plc's first quarter 2023 Revenue $ 1,492.70 millions STE31's Income Statement
Steris Plc's first quarter 2022 Revenue $ 1,210.69 millions Quarterly STE31's Income Statement


STE31 Revenue (Quarter on Quarter Growth %)

2023
2022 2021 2020
4th Quarter March - 1.97 % 1 % 6.98 %
3rd Quarter December - 3.74 % 23.6 % 13.04 %
2nd Quarter September - -13.14 % 10.86 % -18.72 %
1st Quarter June 34.18 % 0.14 % 7.99 % 6.29 %
FY (Year on Year)   - 5.13 % 38.96 % -




Revenue first quarter 2023 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #69
Healthcare Sector #280
Overall #2141

Revenue Y/Y Growth Statistics
High Average Low
47.55 % 12.11 % -73.4 %
(Mar 31 2022)   (Jun 30 2019)
Revenue first quarter 2023 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #69
Healthcare Sector #280
Overall #2141
Revenue Y/Y Growth Statistics
High Average Low
47.55 % 12.11 % -73.4 %
(Mar 31 2022)   (Jun 30 2019)

Revenue by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Steris Plc's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
23.6 % 3.49 % -18.72 %
(Sep 30 2021)  


STE31's I. Quarter Q/Q Revenue Comment
Steris Plc achieved in the I. Quarter 2023 above company average sequential Revenue jump of 34.18%, to $ 1,492.70 millions, from $1,112.43 millions in the fourth quarter.
STE31 is undergoing a remarkable growth, with claiming higher then normal increase, and additionally increasing rate.

Within Medical Equipment & Supplies industry 40 other companies have achieved higher Revenue quarter on quarter growth. While Steris Plc's Revenue growth quarter on quarter, overall rank is 825.


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #41
Healthcare Sector #193
Overall #825
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #41
Healthcare Sector #193
Overall #825
Revenue Q/Q Growth Statistics
High Average Low
23.6 % 3.49 % -18.72 %
(Sep 30 2021)  


STE31's I. Quarter Q/Q Revenue Comment
Steris Plc achieved in the I. Quarter 2023 above company average sequential Revenue jump of 34.18%, to $ 1,492.70 millions, from $1,112.43 millions in the fourth quarter.
STE31 is undergoing a remarkable growth, with claiming higher then normal increase, and additionally increasing rate.

Within Medical Equipment & Supplies industry 40 other companies have achieved higher Revenue quarter on quarter growth. While Steris Plc's Revenue growth quarter on quarter, overall rank is 825.


Steris Plc's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Dec 31 2022)
12 Months Ending
(Sep 30 2022)
12 Months Ending
(Jun 30 2022)
12 Months Ending
(Mar 31 2022)
12 Months Ending
(Dec 31 2021)
Cumulative Revenue 12 Months Ending $ 4,465.70 $ 4,562.24 $ 4,668.29 $ 4,585.06 $ 4,247.91
Y / Y Revenue Growth (TTM) 5.13 % 18.57 % 37.02 % 47.55 % 38.96 %
Year on Year Revenue Growth Overall Ranking # 782 # 370 # 0 # 0 # 0
Seqeuential Revenue Change (TTM) -2.12 % -2.27 % 1.82 % 7.94 % 10.4 %
Seq. Revenue Growth (TTM) Overall Ranking # 2141 # 2098 # 0 # 0 # 0


Cumulative Revenue growth Comment
With the quarterly Revenue reported in the Dec 31 2022 period, Steris Plc's cumulative twelve months Revenue were $ 4,466 millions, company would post below average annual Revenue growth of 10.4% year on year, if the fiscal year would end at Dec 31 2022.
A slow-down in the Steris Plc's Revenue growth from the 1112.43% growth in Sep 30 2022.

In the Healthcare sector 137 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 370 to 782.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 69
Healthcare Sector # 138
Overall # 782

Revenue TTM Y/Y Growth Statistics
High Average Low
47.55 %
12.11 %
-73.4 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 69
Sector # 280
S&P 500 # 2141
Cumulative Revenue growth Comment
With the quarterly Revenue reported in the Dec 31 2022 period, Steris Plc's cumulative twelve months Revenue were $ 4,466 millions, company would post below average annual Revenue growth of -73.4% year on year, if the fiscal year would end at Dec 31 2022.
A slow-down in the Steris Plc's Revenue growth from the 1112.43% growth in Sep 30 2022.

In the Healthcare sector 137 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 370 to 782.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 69
Healthcare Sector # 138
Overall # 782

Revenue TTM Y/Y Growth Statistics
High Average Low
47.55 %
12.11 %
-73.4 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 69
Sector # 280
S&P 500 # 2141




Other Revenue Growth
Medical Equipment & Supplies Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
STE31's Revenue Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue jump for the quarter ending Jun 30 2026 within Healthcare SectorY/Y Change %Revenue for the quarter ending Jun 30 2026
Vyne Therapeutics Inc 40.58%$ 40.580 millions
Qhslab Inc 39.98%$ 39.978 millions
Coherus Oncology inc 39.53%$ 39.526 millions
Neurocrine Biosciences Inc 39.49%$ 39.491 millions
Ss Innovations International Inc39.39%$ 39.393 millions
Assembly Biosciences Inc 38.94%$ 38.936 millions
Edap Tms Sa38.85%$ 38.847 millions
Picard Medical Inc 38.62%$ 38.620 millions
Hims and Hers Health Inc 38.41%$ 38.409 millions
Aquestive Therapeutics Inc 38.15%$ 38.149 millions
Mirum Pharmaceuticals Inc 37.92%$ 37.922 millions
Natera Inc 37.71%$ 37.715 millions
Zomedica Corp 36.59%$ 36.588 millions
Kura Oncology Inc 36.54%$ 36.538 millions
Scientific Industries Inc 36.02%$ 36.022 millions
Ceribell Inc 35.85%$ 35.852 millions
Intelligent Bio Solutions Inc 35.78%$ 35.777 millions
The Pennant Group Inc 35.76%$ 35.755 millions
Quanterix Corporation35.42%$ 35.416 millions
Inspiremd Inc 34.88%$ 34.882 millions
The Oncology Institute Inc 34.62%$ 34.624 millions
Agenus Inc34.36%$ 34.358 millions
Biodesix Inc 34.18%$ 34.184 millions
Myomo Inc 33.82%$ 33.819 millions
Ligand Pharmaceuticals Incorporated33.73%$ 33.733 millions
Biocryst Pharmaceuticals Inc 33.61%$ 33.606 millions
Biofrontera Inc 32.92%$ 32.924 millions
Ironwood Pharmaceuticals inc 32.62%$ 32.617 millions
Cadre Holdings inc 32.56%$ 32.561 millions
Supernus Pharmaceuticals inc 32.40%$ 32.399 millions


About Steris Plc Revenue Growth Rates (STE31), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Steris Plc (CIK 1757898).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001628280-26-054830
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Steris Plc’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.